Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden. (Q53223352)
Jump to navigation
Jump to search
scientific article published on 11 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden. |
scientific article published on 11 October 2006 |
Statements
Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden. (English)
Jonas Lundkvist
Nils Wilking
Stig Holmberg
Linus Jönsson
11 October 2006
102
3
289-299